Can L(+)-lactate be used as a marker of experimentally induced inflammation in rats?

Inflammation Research

Volumn 59, Issue 4, 2010, Pages 315-321

  Finn, Anja ^a   Oerther, Sandra Claudine ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Biomarker; Carrageenan; FCA; Lactate; Prostaglandin

Indexed keywords

BIOLOGICAL MARKER; CARRAGEENAN; CYCLOOXYGENASE 2 INHIBITOR; FREUND ADJUVANT; LACTIC ACID; LACTONE; NAPROXEN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SULFONE;

ANIMAL; ARTHRITIS; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; EDEMA; GENETICS; JOINT; MALE; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; CARRAGEENAN; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EDEMA; FREUND'S ADJUVANT; JOINTS; LACTIC ACID; LACTONES; MALE; NAPROXEN; RATS; RATS, SPRAGUE-DAWLEY; SULFONES;

EID: 77953070921     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0107-6     Document Type: Article

References (33)

1. Egan CG, Lockhart JC, Ferrell WR, Day SM, McLean JS. Pathophysiological basis of acute inflammatory hyperaemia in the rat knee: roles of cyclo-oxygenase-1 and-2. J Physiol. 2002; 539(Pt 2):579-587
2. Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol. 1984;2:335-357
3. Giuliano F, Warner TD. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. J Pharmacol Exp Ther. 2002;303(3):1001-1006
4. Day SM, Lockhart JC, Ferrell WR, McLean JS. Divergent roles of nitrergic and prostanoid pathways in chronic joint inflammation. Ann Rheum Dis. 2004;63(12):1564-1570
5. Xie G, Wang Y, Sharma M, Gabriel A, Mitchell J, Xing Y, et al. 5-Hydroxytryptamine-induced plasma extravasation in the rat knee joint is mediated by multiple prostaglandins. Inflamm Res. 2003;52(1):32-38
6. Birrell GJ, McQueen DS. The effects of capsaicin, bradykinin, PGE2 and cicaprost on the discharge of articular sensory receptors in vitro. Brain Res. 1993;611(1):103-107
7. Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci. 2002;966:343-354
8. Duffy T, Belton O, Bresnihan B, FitzGerald O, FitzGerald D. Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis. Drugs. 2003;63(Suppl 1):31-36
9. Kerins C, Carlson D, McIntosh J, Bellinger L. A role for cyclo-oxygenase II inhibitors in modulating temporomandibular joint inflammation from a meal pattern analysis perspective. J Oral Maxillofac Surg. 2004;62(8):989-995
10. Cicala C, Ianaro A, Fiorucci S, Calignano A, Bucci M, Gerli R, et al. NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol. 2000;130(6):1399-1405
11. Haji-Michael PG, Ladriere L, Sener A, Vincent JL, Malaisse WJ. Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. Metabolism. 1999;48(6):779-785
12. Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol. 2004;558(Pt 1):5-30.
13. Loike JD, Kaback E, Silverstein SC, Steinberg TH. Lactate transport in macrophages. J Immunol. 1993;150(5):1951-1958
14. Kortekangas P, Peltola O, Toivanen A, Aro HT. Synovial fluid L-lactic acid in acute arthritis of the adult knee joint. Scand J Rheumatol. 1995;24(2):98-101.
15. Behn AR, Mathews JA, Phillips I. Lactate UV-system: a rapid method for diagnosis of septic arthritis. Ann Rheum Dis. 1981;40(5):489-492
16. Riordan T, Doyle D, Tabaqchali S. Synovial fluid lactic acid measurement in the diagnosis and management of septic arthritis. J Clin Pathol. 1982;35(4):390-394
17. Gerster JC, Gobelet C. Synovial fluid lactic acid in acute and chronic pyrophosphate arthropathy and in osteoarthritis. Clin Rheumatol. 1988;7(2):197-199
18. Huffman KM, Bowers JR, Dailiana Z, Huebner JL, Urbaniak JR, Kraus VB. Synovial fluid metabolites in osteonecrosis. Rheumatology (Oxford). 2007;46(3):523-528
19. Rioja I, Bush KA, Buckton JB, Dickson MC, Life PF. Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol. 2004;137(1):65-73.
20. Kurihara Y, Endo H, Akahoshi T, Kondo H. Up-regulation of prostaglandin E receptor EP2 and EP4 subtypes in rat synovial tissues with adjuvant arthritis. Clin Exp Immunol. 2001;123(2):323-330
21. Singh HN, Blancuzzi V, Greenwood S, Skiles JW, O'Byrne EM. Synovial fluid levels of tumor necrosis factor-alpha in the inflamed rat knee: modulation by dexamethasone and inhibitors of matrix metalloproteinase and phosphodiesterase. Inflamm Res. 1997;46(Suppl 2):S153-4.
22. Rosseland LA, Krohn CD, Stubhaug A. Synovial fluid concentration of prostaglandin E2 correlates with pain intensity after knee arthroscopic procedures. Anesth Analg. 2007;104(2):460-461
23. Futani H, Okayama A, Matsui K, Kashiwamura S, Sasaki T, Hada T, et al. Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation. J Immunother. 2002;25(Suppl 1):S61-4.
24. Kraus VB, Huebner JL, Fink C, King JB, Brown S, Vail TP, et al. Urea as a passive transport marker for arthritis biomarker studies. Arthritis Rheum. 2002;46(2):420-427
25. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indo-methacin-induced gastric ulceration. Cell. 1995;83(3):483-492
26. Amann R, Lanz I, Schuligoi R. Effects of morphine on oedema and tissue concentration of nerve growth factor in experimental inflammation of the rat paw. Pharmacology. 2002;66(3):169-172
27. Magari K, Miyata S, Ohkubo Y, Mutoh S. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation. Inflamm Res. 2004;53(9):469-474
28. Radhakrishnan R, Moore S, Sluka K. Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperal-gesia in rats. Pain. 2004;104:567-577
29. Schopf LR, Andersson K, Jaffee BD. Rat models of arthritis: similarities, differences, advantages and disadvantages in the identification of novel therapeutics. In: Stevenson CS, Marshall LA, Morgan DW, editors. In vivo models of inflammation. 2nd ed. Berlin: Birkhäuser Verlag; 2006. p. 1-35.
30. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999;5(6):698-701.
31. Pinheiro RM, Calixto JB. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm Res. 2002;51(12):603-610
32. Wallace JL, Chapman K, McKnight W. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in Cg-airpouch inflammation. Br J Pharmacol. 1999;126(5):1200-1204
33. Hashida R, Kuwada M, Chiba KI, Horizoe T, Shirota H, Nagai Y. A factor derived from polymorphonuclear leukocytes enhances interleukin-1-induced synovial cell collagenase and prostaglandin E2 production in rats. Eur J Biochem. 1996;236(2):517-522